Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Shewach

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|August 1, 1995
Radiosensitization of human tumor cells by gemcitabine in vitroD S Shewach, T S Lawrence
Seminars in Oncology|October 1, 1996
Radiosensitization of human solid tumor cell lines with gemcitabineD S Shewach, T S Lawrence
Investigational New Drugs|January 1, 1996
Gemcitabine and radiosensitization in human tumor cellsD S Shewach, T S Lawrence
Seminars in Oncology|April 1, 1997
Gemcitabine-mediated radiosensitizationT S Lawrence, A Eisbruch, D S Shewach
Molecular Pharmacology|September 1, 1992
Nucleotide specificity of human deoxycytidine kinaseD S Shewach, K K Reynolds, L Hertel
Journal of the National Cancer Institute|September 4, 1996
Radiosensitizing nucleosidesC J McGinn, D S Shewach, T S Lawrence
Cancer Research|April 5, 2000
Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyureaP D Boucher, L J Ostruszka, D S Shewach
Cancer Research|September 10, 1998
Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killingL Z Rubsam, B L Davidson, D S Shewach
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitizationT S Lawrence, D K Heimburger, D S Shewach
Human Gene Therapy|May 15, 1998
Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinaseP D Boucher, R J Ruch, D S Shewach
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|August 1, 1995
Radiosensitization of human tumor cells by gemcitabine in vitroD S Shewach, T S Lawrence
Seminars in Oncology|October 1, 1996
Radiosensitization of human solid tumor cell lines with gemcitabineD S Shewach, T S Lawrence
Investigational New Drugs|January 1, 1996
Gemcitabine and radiosensitization in human tumor cellsD S Shewach, T S Lawrence
Seminars in Oncology|April 1, 1997
Gemcitabine-mediated radiosensitizationT S Lawrence, A Eisbruch, D S Shewach
Molecular Pharmacology|September 1, 1992
Nucleotide specificity of human deoxycytidine kinaseD S Shewach, K K Reynolds, L Hertel
Journal of the National Cancer Institute|September 4, 1996
Radiosensitizing nucleosidesC J McGinn, D S Shewach, T S Lawrence
Cancer Research|April 5, 2000
Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyureaP D Boucher, L J Ostruszka, D S Shewach
Cancer Research|September 10, 1998
Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killingL Z Rubsam, B L Davidson, D S Shewach
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitizationT S Lawrence, D K Heimburger, D S Shewach
Human Gene Therapy|May 15, 1998
Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinaseP D Boucher, R J Ruch, D S Shewach
Pageof 7